ArticleJournal of ophthalmic inflammation and infection2026
A rare case of multisystem autoimmune disease presenting with retinopathy and alopecia post COVID-19 vaccination.
Article in Journal of ophthalmic inflammation and infection, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeTo report a case of autoimmune retinopathy (AIR) with multiple systemic involvement
resultsA 45-year-old Asian Indian male presented with progressive blurring of vision in the right eye for five years. Initial best-corrected visual acuity (BCVA) was 20/80 in RE and 20/25 in LE. Clinical evaluation was normal except for a few pigmentary alterations in the periphery. Optical coherence tomography (OCT) later revealed ellipsoid zone loss, and fundus fluorescein angiography showed peripheral venular leakage. Uveitis workup was negative except for a positive T-spot TB; Anti-tubercular therapy for nine months didn't improve the symptoms, with BCVA declining to 20/400 in RE. Fundus autofluorescence demonstrated hypo-autofluorescence in the macula surrounded by hyper-autofluorescence. Review of history revealed dermatological features, including alopecia areata and scalp vitiligo, followed by ocular disease and systemic autoimmune abnormalities. The history also indicated onset about two months after COVID-19 vaccination. Antiretinal and other systemic antibodies were positive. The patient was diagnosed with auto immune retinopathy (AIR) and treated with mycophenolate mofetil, escalating to 1.5 g twice daily. At final follow-up 6 months later, BCVA improved to 20/200 in RE and remained stable in LE, with reduced autofluorescence abnormalities.
conclusionWe report a case of multi system autoimmune disease initially presenting with dermatological features, followed by ocular and other systemic features which may have been triggered following COVID-19 vaccination in an otherwise healthy Indian male. We propose it could be a temporal event and are unable to prove a causal factor. A combination of multimodal imaging with multi-disciplinary approach helped us to come to a final diagnosis in this arduous journey for the patient.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.